XML 92 R85.htm IDEA: XBRL DOCUMENT v2.4.1.9
Commitments and Contingencies (Commitments, Narrative) (Details) (USD $)
In Millions, unless otherwise specified
12 Months Ended 0 Months Ended
Dec. 31, 2014
Dec. 31, 2013
Oct. 29, 2013
Feb. 28, 2014
Product, Kristalose        
Business Acquisition, Contingent Consideration [Line Items]        
Intangible assets, useful life 15 years      
Product, Vaprisol        
Business Acquisition, Contingent Consideration [Line Items]        
Additional upfront payments       $ 2.0cpix_BusinessCombinationAggregateUpfrontPayments
/ us-gaap_BusinessAcquisitionAxis
= cpix_VaprisolMember
Collaborative Arrangement, Amended International Agreement        
Business Acquisition, Contingent Consideration [Line Items]        
Other revenue, potential upfront payment related to product sales   4.0cpix_RevenueRecognitionPotentialUpfrontPaymentRelatedtoProductSales
/ us-gaap_TypeOfArrangementAxis
= cpix_AmendedInternationalAgreementMember
   
Pernix Therapeutics | Collaborative Arrangement, Amended International Agreement        
Business Acquisition, Contingent Consideration [Line Items]        
Other revenue, potential upfront payment related to product sales 3.0cpix_RevenueRecognitionPotentialUpfrontPaymentRelatedtoProductSales
/ dei_LegalEntityAxis
= cpix_PernixTherapeuticsMember
/ us-gaap_TypeOfArrangementAxis
= cpix_AmendedInternationalAgreementMember
  $ 4.0cpix_RevenueRecognitionPotentialUpfrontPaymentRelatedtoProductSales
/ dei_LegalEntityAxis
= cpix_PernixTherapeuticsMember
/ us-gaap_TypeOfArrangementAxis
= cpix_AmendedInternationalAgreementMember